HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure
Clinical trial NCT06375317 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06375317
- Sponsor
- Yehua Shen
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-30
- Primary completion
- 2026-04-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.